Clinical Trial Results: Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dendritic cell/tumor fusions with GM-CSF and Imiquimod in ovarian cancer and related peritoneal cancers; study terminated with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Dendritic cell/tumor fusions with GM-CSF and Imiquimod

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Ovarian Cancer, Primary Peritoneal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2026-08-05